Get all your news in one place.
100's of premium titles.
One app.
Start reading
MarketBeat
MarketBeat
Business
Chris Markoch

Could Palantir’s R1 Deal Be the Catalyst for a Stock Surge?

Palantir Technologies Inc. (NASDAQ: PLTR) stock is finding support around its 15-day simple moving average after the company announced a partnership with R1 to launch R37, an AI-driven lab focused on improving healthcare financial operations.

[content-module:CompanyOverview|NASDAQ:PLTR]

This is the latest in a series of new and renewed contracts that Palantir has announced in the last 30 days. Each of these contracts adds to the company’s top line, which is well below its lofty valuation.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.